glp-1 summit Professional Employer Coverage of GLP-1 Drugs
Description
Kidney protection The FLOW trial with semaglutide demonstrated significant kidney protective effects in patients with Type 2 diabetes and chronic kidney disease
By delaying stomach emptying, they allow your body to release glucose gradually, preventing blood sugar spikes and keeping you full longer
Mann JFE, Fonseca VA, Poulter NR, et al
2024 doi: 10.1007/s00210-024-03532-7
